IL 12 as an adjuvant for vaccines designed to prevent infection and immunopathology by schistosomes

This publication has 25 references indexed in Scilit:

• Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.
  The Journal of Experimental Medicine, 1995
• Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites.
  The Journal of Experimental Medicine, 1994
• Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones.
  The Journal of Experimental Medicine, 1994
• Differential effects of interleukin‐12 on the development of naive mouse CD4⁺ T cells
  European Journal of Immunology, 1994
• Development of T _H 1 CD4 ⁺ T Cells Through IL-12 Produced by Listeria -Induced Macrophages
  Science, 1993
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• The Importance of Th2 Cytokines in Protective Immunity to Nematodes
  Immunological Reviews, 1992
• Fibrogenic cytokines: the role of immune mediators in the development of scar tissue
  Immunology Today, 1991
• Where and how does immune elimination of Schistosoma mansoni occur?
  Parasitology Today, 1989
• Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.
  The Journal of Experimental Medicine, 1989